Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Founded in 2016, Infervision stands at the forefront of AI-driven medical technology, dedicated to enhancing multidisciplinary healthcare services and operations through innovative artificial intelligence solutions. Their advanced AI offerings are designed to assist healthcare professionals across a spectrum of tasks, including disease screening, diagnosis, intervention, treatment, patient management, and medical research. Among their array of solutions, InferRead CT Lung specializes in detecting lung nodules from chest CT scans, while InferRead DR Chest focuses on identifying chest abnormalities via X-ray imaging. Moreover, InferRead CT Coronary is tailored for recognizing coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is adept at triaging hemorrhages from brain CT scans. The company also provides InferRead CT Bone for spotting chest fractures in CT images and InferRead CT Pneumonia for diagnosing and managing pneumonia cases. Beyond these, their offerings extend to InferOperate, which facilitates 3D reconstruction for thoracic, liver, and urological surgical procedures, and InferCare, a tool designed for effective patient management and image follow-up. Additionally, InferScholar acts as an AI-enhanced resource for medical research, further solidifying Infervision's commitment to transforming healthcare through AI technology. This comprehensive suite of solutions positions Infervision as a pivotal player in the evolution of medical practices.
Description
Active Inference represents an innovative approach to agentic AI, grounded in world models and stemming from more than three decades of exploration in computational neuroscience. This paradigm facilitates the development of AI solutions that prioritize both power and computational efficiency, specifically tailored for on-device and edge computing environments. By seamlessly integrating with established computer vision frameworks, our intelligent decision-making systems deliver outputs that are not only explainable but also empower organizations to instill accountability within their AI applications and products. Furthermore, we are translating the principles of active inference from the realm of neuroscience into AI, establishing a foundational software system that enables robots and embodied platforms to make autonomous decisions akin to those of the human brain, thereby revolutionizing the field of robotics. This advancement could potentially transform how machines interact with their environments in real-time, unlocking new possibilities for automation and intelligence.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Infervision
Founded
2016
Country
United States
Website
global.infervision.com
Vendor Details
Company Name
Stanhope AI
Founded
2021
Country
United Kingdom
Website
www.stanhopeai.com
Product Features
Product Features
Artificial Intelligence
Chatbot
For Healthcare
For Sales
For eCommerce
Image Recognition
Machine Learning
Multi-Language
Natural Language Processing
Predictive Analytics
Process/Workflow Automation
Rules-Based Automation
Virtual Personal Assistant (VPA)